|
Press Releases
Publications
Factsheets
Popular
Pubs
Scientific & Technical Pubs
Industry Alerts & Tech Notes
Videos
Art &
Symbols
Email
Us
![jump over repetitive sidebar navigation](https://webarchive.library.unt.edu/eot2008/20090109033834im_/http://www.aphis.usda.gov/images/spacer.gif)
Privacy Statement
EEO Statement
USDA
| MRP
APHIS Home Page
|
|
Stakeholders Announcement
USDA Begins Field Trial for White-Tailed Deer Populations
Wildlife Services
September 15, 2004
The U.S. Department of Agriculture’s Animal and Plant Health
Inspection Service’s National Wildlife Research Center (NWRC)
is testing a new contraceptive product in Maryland, a gonadotropin-releasing
hormone (GnRH), designed to humanely reduce white-tailed deer populations.
NWRC scientists developed a gonadotropin-releasing hormone (GnRH) immunocontraceptive
that displays great promise as a wildlife infertility agent. GnRH is
a hormone naturally produced at the base of the brain that controls
the production of sperm in males and ovulation in females. The immunocontraceptive
works by inhibiting the release of these hormones, rendering deer sterile
or infertile for up to two years.
Large deer populations, particularly those inhabiting fenced or other
enclosed areas in urban or suburban areas where hunting is not an alternative,
present serious problems for wildlife managers, landowners, airports
and the general public. Problems associated with overabundant deer herds
include increased collisions between deer and motor vehicles, increased
frequency of conflicts between deer and humans, greater potential for
disease transmission among deer, reduction in the general health of
deer and increased damage to local native vegetation due to overbrowsing.
APHIS is conducting these trials by providing a single-dose contraceptive
to females (does) in an enclosed population of free-ranging white-tailed
deer to inhibit reproduction. WS biologists injected, tagged and attached
radio telemetry transmitters to approximately 30 does and will compare
results to noninjected does in an adjacent deer population for a period
of two years to determine the effectiveness of the GnRH vaccine. During
this period, normal reproductive activities in treated does is expected
to decrease, cause reduced and no interest from the male species and
greatly reduce behavioral tendencies commonly associated with the rutting
season.
APHIS’ NWRC is devoted to the resolution of conflict caused by
the interaction of wild animals and society. The center applies scientific
expertise to the development of practical methods to resolve these problems
and to maintain the quality of the environments shared by humans and
wildlife.
#
Note to Stakeholders: Stakeholder announcements
and other APHIS information are available on the Internet. Go to the
APHIS home page at http://www.aphis.usda.gov
and click on the “News” button. For additional information
on this topic, contact Daniel Parry (301) 734-3255 or daniel.j.parry@aphis.usda.gov
The U.S. Department of Agriculture (USDA) prohibits discrimination
in all its programs and activities on the basis of race, color, national
origin, sex, religion, age, disability, political beliefs, sexual orientation,
or marital or family status. (Not all prohibited bases apply to all
programs.) Persons with disabilities who require alternative means for
communication of program information (Braille, large print, audiotape,
etc.) should contact USDA’s TARGET Center at (202) 720–2600
(voice and TDD).
To file a complaint of discrimination, write USDA, Director, Office
of Civil Rights, Room 326–W, Whitten Building, 1400 Independence
Avenue, SW, Washington, DC 20250–9410 or call (202) 720–5964
(voice and TDD). USDA is an equal opportunity provider and employer.
Click here for printable version
(PDF)
|
|